Latest neck cancers Stories
Curcumin, the major component in the spice turmeric, when combined with the drug Cisplatin enhances the chemotherapy's suppression of head and neck cancer cell growth.
CALGARY, July 29 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.
CALGARY, July 19 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.
CALGARY, June 1 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.
ROCKVILLE, Md., May 27 /PRNewswire-USNewswire/ -- An advanced type of cancer radiation is more successful than traditional radiation in avoiding "dry mouth" when treating head and neck cancers, but it is unknown whether the treatment is better or worse at reducing the size of tumors, according to a new comparative effectiveness review funded by HHS' Agency for Healthcare Research and Quality. The report finds that intensity-modulated radiation therapy (IMRT) leads to fewer cases of...
CALGARY, May 25 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) today announced that it has opened enrollment in its Phase 3 trial examining REOLYSIN in combination with paclitaxel and carboplatin in patients with platinum-refractory head and neck cancers.
Charleston, S.C., April 7 /PRNewswire/ -- Citing the now well-established link between oral human papillomavirus (HPV) infection and cancers of the tongue, throat and tonsils, the Head and Neck Cancer Alliance (HNCA) has expanded its list of at-risk populations for oral, head and neck cancers to include sexually active adults who engage in common sexual behaviors, such as open-mouth kissing and oral sex.
CALGARY, March 9 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.
-- Company to Host Clinical Update Conference Call -- CALGARY, Feb. 16 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) today announced that it has received a letter of approval from the U.K.
Patients with head and neck cancer linked to high risk human papillomavirus, or HPV, have worse outcomes if they are current or former tobacco users, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center.